CMG Pharmaceutical Co Ltd (058820) Stock Price & News

058820:KOSDAQ

CMG Pharmaceutical Co Ltd

₩4,130.00

+0.73%

(+30.00) 1D

Nov 4, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 058820...

Open

₩4,075

High

₩4,155

Low

₩4,035

Mkt. cap

61.18B

Avg. vol.

164.73K

Volume

35.32K

P/E ratio

13.11

52-wk high

₩22,050

52-wk low

₩3,920

EPS

₩315

Shares outstanding

14.81M

No. of employees

242

Open

₩4,075

High

₩4,155

Low

₩4,035

Mkt. cap

61.18B

Avg. vol.

164.73K

Volume

35.32K

P/E ratio

13.11

52-wk high

₩22,050

52-wk low

₩3,920

EPS

₩315

Shares outstanding

14.81M

No. of employees

242

Related stocks

Saudi Printing and Packaging Cmpny SJSC

SAR 44.40

-1.81%

News stories

From web sources and news partners

FinancialContent

39 minutes ago

Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings

WTTW News

56 minutes ago

Dow Has Best Post-Midterm Elections Day in 44 Years as Democrats Take Control of Congress

MarketWatch

40 minutes ago

This year’s worst-performing S&P 500 stock is finally seeing some major relief

PBS

2 hours ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About CMG Pharmaceutical Co Ltd

CEO-

Employees242

Founded2001

Headquarters-

SectorPharmaceutical industry

Industry-

Websitecmgpharma.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	30.40B	31.53B	25.52B	28.26B
Cost of goods sold	12.51B	13.54B	11.86B	13.33B
Cost of revenue	12.51B	13.54B	11.86B	13.33B
Research and development expenses	68.37M	362.68M	165.01M	392.58M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	15.38B	15.84B	15.40B	16.13B
Operating expense	16.68B	16.96B	16.58B	17.88B
Total operating expenses	29.20B	30.50B	28.44B	31.21B
Operating income	1.21B	1.04B	-2.92B	-2.95B
Other non operating income	2.33B	1.24B	-300.95M	-1.76B
EBT including unusual items	5.73B	-4.04B	111.08M	2.85B
EBT excluding unusual items	5.29B	3.77B	111.08M	-2.97B
Income tax expense	-734.19K	-706.00M	-1.68M	715.29M
Effective tax rate	-0.01%	17.48%	-1.51%	25.12%
Other operating expenses	197.11M	200.60M	168.42M	181.47M
Net income	5.73B	-3.33B	112.76M	2.13B
Net profit margin	18.84%	-10.57%	0.44%	7.54%
Earnings per share	-	-	-	-
Interest and investment income	614.48M	498.52M	418.54M	388.68M
Interest expense	-619.49M	-303.11M	-95.12M	-11.97M
Net interest expenses	-5.00M	195.41M	323.41M	376.70M
Depreciation and amortization charges	244.60M	235.60M	224.01M	215.20M
EBITDA	1.91B	1.74B	-2.26B	-2.34B
Gain or loss from assets sale	-39.93M	1.99K	1.00K	-1.69M

Finance

Ask anything